Survival analysis of BC patients indicates that high mRNA level of BCL9L is significantly correlated with worse overall survival in bladder cancer patients, suggesting that a BCL9L high level might not be beneficial in BC patients. The gene discussed is BCL9L; the disease is urinary bladder carcinoma.